| 000 | 01734 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517000613.0 | ||
| 264 | 0 | _c20160120 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1557-8534 | ||
| 024 | 7 |
_a10.1089/scd.2014.0390 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQi, Shuqun | |
| 245 | 0 | 0 |
_aCell-based therapy for therapeutic lymphangiogenesis. _h[electronic resource] |
| 260 |
_bStem cells and development _cFeb 2015 |
||
| 300 |
_a271-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 |
_aEmbryonic Stem Cells _xtransplantation |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 | _aGene Expression Regulation, Developmental |
| 650 | 0 | 4 |
_aHomeodomain Proteins _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInduced Pluripotent Stem Cells _xtransplantation |
| 650 | 0 | 4 |
_aLymphangiogenesis _xdrug effects |
| 650 | 0 | 4 |
_aLymphatic System _xphysiology |
| 650 | 0 | 4 |
_aLymphedema _xsurgery |
| 650 | 0 | 4 |
_aMesenchymal Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aPostoperative Complications _xsurgery |
| 650 | 0 | 4 | _aRegeneration |
| 650 | 0 | 4 |
_aTranscription Factors _xphysiology |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xphysiology |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor C _xpharmacology |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-3 _xdeficiency |
| 650 | 0 | 4 | _aProspero-Related Homeobox 1 Protein |
| 700 | 1 | _aPan, Jian | |
| 773 | 0 |
_tStem cells and development _gvol. 24 _gno. 3 _gp. 271-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/scd.2014.0390 _zAvailable from publisher's website |
| 999 |
_c24291912 _d24291912 |
||